Particularities of Neurological Manifestations in Adult T-Cell Leukemia/Lymphoma: Need for a Multidisciplinary Approach-A Narrative Review.
Iuliana IordanMinodora-Cezarina OnisâiAna-Maria VlădăreanuCristina MambetElena Cristina MarinescuRaluca NistorHoria BumbeaPublished in: Medicina (Kaunas, Lithuania) (2022)
ATL is a rare but a highly aggressive T-cell neoplasm associated with human T-cell leukemia virus-1 (HTLV-1) infection. Human T-cell lymphotropic virus type-1 (HTLV-1) is a oncogenic retrovirus responsible for the development of adult T-cell leukemia (ATL), but also for other non-malignant diseases, such as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). HTLV-1 has a higher prevalence in Japan, the Caribbean, South America, intertropical Africa, Romania, and northern Iran. ATL patients can have an extensive spectrum of neurological manifestations. Numerous factors can be implicated, such as central nervous system infiltrates, neurolymphomatosis, complications to medication or allogeneic stem cell transplantation, HAM/TSP, infections, metabolic disturbances. The neurological complications are not always easy to recognize and treat. Thus, this review underlines the necessity of a multidisciplinary approach in ATL patients with neurological symptomatology.
Keyphrases
- stem cell transplantation
- bone marrow
- endothelial cells
- high dose
- acute myeloid leukemia
- end stage renal disease
- chronic kidney disease
- ejection fraction
- induced pluripotent stem cells
- pluripotent stem cells
- cerebral ischemia
- healthcare
- quality improvement
- transcription factor
- low dose
- young adults
- cerebral palsy
- childhood cancer
- botulinum toxin